Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.
Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. · 2016
Read Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. by Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4855534.txt.
Introduction
Abigail S. Krall and co-authors showed in Nature Communications in 2016 that asparagine, a building-block amino acid, helps cancer cells grow by acting as a trade token. Cells swap inner asparagine for outside amino acids, the study found. Lowering the cell's asparagine, by cutting its making enzyme or starving the dish, slowed uptake of other amino acids, above all serine, arginine, and histidine.
That trade feeds a growth switch called mTORC1 and keeps protein making high. Serine uptake under asparagine control also shapes serine use and the making of DNA letters. Asparagine thus coordinates protein and DNA supply at once, which may explain why some cancers lean hard on it.
Catalog record
| CREATOR | Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor By Abigail S Krall, Shili Xu, Thomas G Graeber, Daniel Braas, Heather R Christofk Published in: Nature Communications DOI: 10.1038/ncomms11457 ABSTRACT Abstract Cellular amino acid uptake is critical for mTOR complex 1 (mTORC1) activation and cell proliferation. However, the regulation of amino acid uptake is not well-understood. Here we describe a role for asparagine as an amino acid exchange factor: intracellular asparagine exchanges with extracellular amino acids. Through asparagine synthetase knockdown and altering of media asparagine concentrations, we show that intracellular asparagine levels regulate uptake of amino acids, especially serine, arginine and histidine. Through its exchange factor role, asparagine regulates mTORC1 activity and protein synthesis. In addition, we show that asparagine regulation of serine uptake influences serine metabolism and nucleotide synthesis, suggesting that asparagine is involved in coordinating protein and nucleotide synthesis. Finally, we show that maintenance of intracellular asparagine levels is critical for cancer cell growth. Collectively, our results indicate that asparagine is an important regulator of cancer cell amino acid homeostasis, anabolic metabolism and proliferation. Many tumour cells exhibit high rates of glutamine consumption to support macromolecular biosynthesis and cell proliferation1. Glutamine fuels the tricarboxylic acid (TCA) cycle through anaplerosis and contributes to the synthesis of lipids, nucleotides and non-essential amino acids. However, the full spectrum of glutamine contribution to cancer cell growth remains an area of active investigation. Although glutamine can contribute to synthesis of several amino acids through its catabolism to glutamate, only asparagine requires glutamine for de novo synthesis; glutamine is a substrate for asparagine synthetase (ASNS). ASNS activity is unidirectional and ATP-dependent, suggesting that cells synthesize asparagine at the expense of macromolecule synthesis and cellular energy. The importance of asparagine for tumour growth has been demonstrated by the effectiveness of extracellular asparaginase in treating low-ASNS-expressing leukaemia. Notably, the off-target glutaminase (GLS) activity of asparaginase is not required for its anti-tumour effects2. Although asparaginase is effective as a therapeutic for cancers that obtain the majority of their asparagine from the environment, cancers that are capable of synthesizing asparagine de novo via ASNS are less responsive to asparaginase therapy3. Moreover, leukaemic asparaginase resistance is associated with elevated ASNS expression4, and ASNS expression in solid tumours correlates with tumour grade and poor prognosis5. Recently, genetic silencing of ASNS in sarcoma cells combined with depletion of plasma asparagine levels via asparaginase was shown to blunt tumour growth in vivo6. Thus, cancer cells appear to have high demand for asparagine, and this demand has the potential to be exploited therapeutically. The nature of ASNS regulation suggests that asparagine may play a role in cellular amino acid homeostasis. ASNS expression is upregulated in response to individual or combined limitation of numerous amino acids, including most essential amino acids7,8. Amino acid-starvation-induced upregulation of ASNS is mediated by activating transcription factor 4 (ATF4), the transcriptional activity of which is activated in response to uncharged tRNAs. Although ATF4 regulates expression of genes involved in multiple amino acid synthesis and transport pathways, asparagine alone rescues the impaired proliferation and autophagy resulting from induced ATF4 knockdown9, supporting the idea that asparagine globally impacts intracellular amino acid levels. However, the only currently known function for asparagine is as a substrate for protein synthesis. Here we identify a novel role for asparagine as an amino acid exchange factor. We show that asparagine exchanges with extracellular amino acids to regulate mTOR complex 1 (mTORC1) activation, nucleotide synthesis and proliferation. Our results indicate that glutamine contribution to cancer cell survival and proliferation is, in part, mediated by glutamine-dependent asparagine synthesis. RESULTS Glutamine independence confers asparagine dependence The broad contribution of glutamine carbon and nitrogen to cancer metabolism has led to the development of drugs targeting glutamine metabolism such as CB-839, an orally bioavailable GLS inhibitor currently undergoing Phase I evaluation for cancer treatment10,11,12. We hypothesized that glutamine-dependent cancers may generate resistance to drugs targeting glutamine metabolism by increasing reliance on metabolites downstream of glutamine. To test this hypothesis, we generated both LPS2 liposarcoma cells that grow in the absence of glutamine and SUM159PT breast cancer cells that are resistant to CB-839 (ref. 10; Supplementary Fig. 1a). Since glutamine is required for de novo asparagine synthesis, we examined whether resistance to glutamine withdrawal confers growth dependence on exogenous asparagine. Also, since CB-839-resistant cells downregulate cellular glutamine consumption (Supplementary Fig. 1b), thereby limiting glutamine availability for the ASNS reaction, we examined whether resistance to GLS inhibition confers growth dependence of exogenous asparagine as well. LPS2 glutamine-independent and SUM159PT CB-839-resistant cells, but not their parental cells, require asparagine in the cell culture medium for proliferation (Fig. 1a–d). LPS2 glutamine-independent cells increase expression of glutamine synthetase (GS) (Supplementary Fig. 1c), likely to fulfil cellular glutamine requirements for nucleotide and protein synthesis by synthesizing glutamine from glutamate13. However, the dependence of glutamine-independent cells on exogenous asparagine indicates that GS-derived glutamine is insufficient to fulfil the cellular demand for asparagine and suggests that maintaining intracellular asparagine levels is critical for proliferation. Dependence of glutamine-independent cells on exogenous asparagine for proliferation is consistent with a recent report that exogenous asparagine protects cells from apoptosis on glutamine deprivation5. [Figure: Resistance to glutamine withdrawal or glutaminase inhibition causes cellular asparagine dependence.(a–d) Proliferation curves of LPS2 parental, LPS2 glutamine (Q)-independent, SUM159PT parental and SUM159PT CB-839-resistant cells in the presence or absence of 0.1 mM asparagine (N) in the medium. (e) Percentages of intracellular 13C-labelled asparagine in LPS2 parental and glutamine-independent, as well as SUM159PT parental and CB-839-resistant cells labelled with U-13C-asparagine in the medium for 24 h, as determined by LC-MS. (f) The per cent change in medium asparagine levels as determined by LC-MS after 24-h incubation time for the indicated cells or for medium in an empty tissue culture plate (blank). Error bars denote s.d. of the mean (n=3). P values were calculated by the Student's t-test: *P<0.05; **P<0.01; ***P<0.001; NS, not significant.] Given the structural similarity of asparagine and glutamine, we examined whether asparagine could be metabolized like glutamine as a potential resistance mechanism to glutamine deprivation and GLS inhibition. To determine if blocking glutamine metabolism causes cells to catabolize asparagine, we labelled the cell culture medium with either asparagine uniformly labelled on carbon (U-13C-asparagine) or uniformly labelled on nitrogen (U-15N-asparagine). The only detected metabolites labelled with asparagine carbon in the resistant cells are small percentages of aspartate and malate (Supplementary Fig. 1d). Asparagine nitrogen is detected in ∼10% of purines (Supplementary Fig. 1e). However, both the U-13C-asparagine and U-15N-asparagine utilized in these experiments are contaminated with small percentages of labelled aspartate, and the observed label on aspartate, malate and purines is likely due to this contamination and the increased consumption of aspartate by the resistant cells (Supplementary Fig. 1f). These data suggest that asparagine is not widely catabolized in LPS2 glutamine-independent cells, SUM159PT CB-839-resistant cells or their parental counterparts. Since cells resistant to glutamine withdrawal and GLS inhibition require exogenous asparagine for proliferation but do not seem to catabolize it, we considered that the resistant cells may require exogenous asparagine simply for protein synthesis. To examine this possibility, we tested whether the LPS2 cells resistant to glutamine withdrawal and/or the SUM159PT cells resistant to GLS inhibition consume more 13C-asparagine from the medium than